Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Under-use of platelet antiaggregants in patients with cardiovascular disease].

× No keyword cloud information.

6 in total

1. [Clinical characteristics, prognosis, and variability in the management of non-ST-segment elevation acute coronary syndromes. Data from the PEPA registry].

Authors: Xavier Bosch; Esteban López De Sá; José López Sendón; Jaime Aboal; Faustino Miranda-Guardiola; Armando Bethencourt; Rafael Rubio; Raúl Moreno; Luis Martín Jadraque; Inmaculada Roldán; Ramón Calviño; Vicente Valle; Félix Malpartida
Journal: Rev Esp Cardiol Date: 2003-04 Impact factor: 4.753

2. [Role of emergency departments in acute myocardial infarction care. EVICURE study].

Authors: Angel Loma-Osorio; Luis García-Castrillo; Fernando Arós; Pedro Lopetegui; Enrique Recuerda; Francisco Epelde
Journal: Rev Esp Cardiol Date: 2002-10 Impact factor: 4.753

3. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors:
Journal: BMJ Date: 2002-01-12

4. [Meta-analysis of the scientific evidence on the usefulness of sporadic intake of acetylsalicylic acid in the prevention of coronary heart disease].

Authors: Gloria Pueyo; Roberto Elosua; Jaume Marrugat
Journal: Med Clin (Barc) Date: 2002-02-16 Impact factor: 1.725

5. [Intervention program to improve secondary prevention of myocardial infarction. Results of the PRESENTE (early secondary prevention) study].

Authors: José A de Velasco; Juan Cosín; Manuel de Oya; Eduardo de Teresa
Journal: Rev Esp Cardiol Date: 2004-02 Impact factor: 4.753

6. [New data on secondary prevention of myocardial infarction in Spain. Results of the PREVESE II study].

Authors: José A De Velasco; Juan Cosín; José Luis López-Sendón; Eduardo De Teresa; Manuel De Oya; Guillermo Sellers
Journal: Rev Esp Cardiol Date: 2002-08 Impact factor: 4.753

6 in total